[Marine-dental experiences with the symptomatic local drug Corti-Dynexan].
D000287:Administration, Topical; D000328:Adult; D000535:Aluminum / Q000627:therapeutic use; D003868:Dequalinium / Q000627:therapeutic use*; D004338:Drug Combinations; D005561:Formates / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008885:Military Dentistry; D009326:Naval Medicine; D009824:Ointments; D010194:Pancreatin / Q000627:therapeutic use*; D010510:Periodontal Diseases / Q000628:therapy*; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use* / Q000031:analogs & derivatives; D011806:Quinolinium Compounds / Q000627:therapeutic use*; D014449:Tyrothricin / Q000627:therapeutic use*
D004338:Drug Combinations; D005561:Formates; D009824:Ointments; D011806:Quinolinium Compounds; D014449:Tyrothricin; D011092:Polyethylene Glycols; C010898:Corti-Dynexan; D010194:Pancreatin; D011239:Prednisolone; D000535:Aluminum; D003868:Dequalinium
Marinezahnärztliche Erfahrungen mit dem symptomatischen Lokaltherapeutikum Corti-Dynexan